Ain Holdings Inc. · TSE:9627
Ain — Q3 FY4/20 Earnings Presentation
13 slides from Ain's earnings presentation, Mar 4, 2020
Slide 1: FY4/20 3Q IR Presentation
FY4/20 3Q IR PRESENTATION March 2020
Slide 2: Results Overview
Results Overview © 2020 AIN HOLDINGS INC. All Rights Reserved. 1
Slide 3: Consolidated P/L
Consolidated P/L Net sales increased 8.7% YoY and decreased 0.6% against the plan due to contribution of 26 stores opened(including M&A) in this fiscal year and store opened in previous year. Ordinary income up 4.7% YoY and declined 6.1% against the plan due to net sales lower than forecast and larg
Slide 4: Dispensing Pharmacy Business (Consolidated)
Dispensing Pharmacy Business (Consolidated) Net sales increased 9.7% YoY and 0.1% against the plan due to the full contribution of stores opened in previous year and increase in average prescription price. Segment income up 15.4% YoY and declined 4.6% against the plan due to the large pharmacies ope
Slide 5: Cosmetic and Drug Store Business (Consolidated)
Cosmetic and Drug Store Business (Consolidated) Net sales increased 6.0% YoY due to the full contribution of stores opened in previous year and decreased 4.9% against the plan due to inclement weather and effect of inbound demand. Segment income decreased 22.4% YoY and 35.9% against the plan due to
Slide 6: Consolidated B/S
Consolidated B/S Net cash became ¥38,629million due to repayment of debts and shareholders’ equity ratio became 58.0%. We are maintaining a sound financial structure. (¥ million) (¥ million) End-FY4/19 End-FY4/20 3Q Assets Liabilities Assets Liabilities Current assets 85,446 Current liabilities 73,7
Slide 7: Assets
Assets The balance of total assets decreased ¥958 million from the end of the previous fiscal year. Mainly reflected an decrease in cash on hand and in banks and goodwill. (¥ million) End-FY4/19 3Q End-FY4/19 End-FY4/20 3Q Change Cash on hand and in banks 53,494 48,091 46,276 (1,815) Notes and accou
Slide 8: Liabilities and Net Assets
Liabilities and Net Assets The balance of liabilities decreased ¥6,110 million from the end of the previous fiscal year due to the repayment of debts etc. (¥ million) End-FY4/19 3Q End-FY4/19 End-FY4/20 3Q Change Accounts payable 43,016 44,794 46,784 +1,990 Short-term debt 6,935 5,571 4,196 (1,375)
Slide 9: Revised Plan
Revised Plan © 2020 AIN HOLDINGS INC. All Rights Reserved. 8
Slide 10: FY4/20 Revised Plan (Consolidated)
FY4/20 Revised Plan (Consolidated) The group has revise the forecast for the fiscal year ending April 30, 2020. Net sales increase 6.4% and ordinary income increase 3.4% YoY due to tightening the criteria for M&A deals and a slowdown in consumer spending amid the COVID-19 outbreak, as well as large-
Slide 11: FY4/20 Revised Plan (Dispensing Pharmacy Business)
FY4/20 Revised Plan (Dispensing Pharmacy Business) Vs original FY4/19 FY4/20 FY4/20 YoY （¥ million） plan change results original plan revised plan (%) change (%) Net sales 245,003 266,850 263,760 (1.2) +7.7 Gross profit 32,741 37,020 35,640 (3.7) +8.9 % of net sales 13.4 13.9 13.5 SG&A expenses 14,8
Slide 12: FY4/20 Revised Plan (Cosmetic and Drug Store Business)
FY4/20 Revised Plan (Cosmetic and Drug Store Business) Vs original FY4/19 FY4/20 FY4/20 YoY （¥ million） plan change results original plan revised plan (%) change (%) Net sales 25,210 28,500 25,400 (10.9) +0.8 Gross profit 9,535 10,930 9,980 (8.7) +4.7 % of net sales 37.8 38.4 39.3 SG&A expenses 8,63
Slide 13: AIN HOLDINGS INC. Corporate Planning Division
Inquiries related to this presentation should be addressed to AIN HOLDINGS INC. Corporate Planning Division TEL(81)11-814-0010 FAX(81)11-814-5550 https://www.ainj.co.jp/ This document may not be reproduced or distributed to any third party without prior approval of AIN HOLDINGS INC. This document ha